Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Colorcon
Harvard Business School
Teva
Moodys
Chubb

Generated: September 19, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Lucerastat

  Try a free trial


See Plans and Pricing

« Back to Dashboard

US Patents for Lucerastat

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Lucerastat ➤ Sign Up Method for treatment of CNS-involved lysosomal storage diseases Monsanto Company (St. Louis, MO) ➤ Sign Up
Lucerastat ➤ Sign Up Use of alkylated iminosugars to treat multidrug resistance G.D. Searle & Company (Chicago, IL) ➤ Sign Up
Lucerastat ➤ Sign Up Use of glucosidase inhibitors for therapy of mucovisidosis Centre National de la Recherche Scientifique (C.N.R.S.) (Paris, FR) Universite de Poitiers (Poitiers, FR) ➤ Sign Up
Lucerastat ➤ Sign Up Use of glucosidase inhibitors for therapy of mucovisidosis Centre National de la Recherche Scientifique (C.N.R.S.) (Paris, FR) Universite de Poitiers (Poitiers, FR) ➤ Sign Up
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

Subscribe to access the full database, or try a Free Trial

International Patents for Lucerastat

Drugname Country Document Number Estimated Expiration Related US Patent
Lucerastat Austria 148456 2013-05-13 ➤ Sign Up
Lucerastat Austria 268598 2013-05-13 ➤ Sign Up
Lucerastat Australia 5813898 2013-05-13 ➤ Sign Up
Lucerastat Australia 6783294 2013-05-13 ➤ Sign Up
Lucerastat Canada 2159988 2013-05-13 ➤ Sign Up
Lucerastat Canada 2278507 2013-05-13 ➤ Sign Up
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
US Department of Justice
Argus Health
McKesson
Citi
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.